By Deena Beasley July 22 (Reuters) - Biotech experts and industry executives are calling plans by the U.S. Food and Drug ...

Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese ...

Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and financial improvements.

Ionis Pharmaceuticals' shares are down more than 27% so far this year. What does Cathie Wood see that others are missing?

Biotechnology investors remain confident in the sector's outlook even after a major comeback this year — and they're picking their positions. The healthcare subsector has quietly become one of the ...

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

China’s nascent challenge has U.S. biotech startups hustling to emulate China’s efficiency and speed in drug development.

A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.

A group of 61 biopharma companies, executives and investors has filed an amicus brief in support of the FDA in an ongoing case brought by Louisiana meant to remove access to the abortion pill ...

On paper, it was another strong quarter for Carvykti. Johnson & Johnson reported record sales for the CAR-T therapy, signaling robust demand in multiple myeloma. | On paper, it was another strong ...